Kala Pharmaceuticals Inc

$0.36 0.00% ($0.00)

Get ready to invest

About Kala Pharmaceuticals Inc

Kala Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapies for diseases of the eye. The Company's product candidate includes EYSUVIS (loteprednol etabonate ophthalmic suspension) 0.25% and INVELTYS (loteprednol etabonate ophthalmic suspension) 1%. Its EYSUVIS (loteprednol etabonate ophthalmic suspension) 0.25%, is a short-term (up to two weeks) treatment of the signs and symptoms of dry eye disease. INVELTYS (loteprednol etabonate ophthalmic suspension) 1%, is a topical twice-a-day ocular steroid for the treatment of post-operative inflammation and pain following ocular surgery. The Company's AMPPLIFY technology uses selectively-sized nanoparticles that each have a proprietary coating. Its Preclinical Development Programs include rTKI Program for Retinal Diseases (KPI-285/KPI-286), SEGRM Program and Surface Targeted Steroid Program (KPI-333).

Popular Stocks	Price	Change
Southwestern Energy SWN	$7.01 7.35%	7.35%
AMC AMC	$12.47 3.49%	3.49%
AMD AMD	$87.08 5.64%	5.64%
SoFi Technologies, Inc. SOFI	$6.13 6.06%	6.06%
ContextLogic WISH	$1.95 2.99%	2.99%
Bank of America BAC	$32.31 0.72%	0.72%
Apple AAPL	$141.66 2.45%	2.45%
Carnival CCL	$10.85 12.44%	12.44%
Amazon AMZN	$116.46 3.58%	3.58%
Ginkgo Bioworks Holdings DNA	$2.86 2.72%	2.72%